Cargando…
Racial Disparities in Diabetes Technology Adoption and Their Association with HbA1c and Diabetic Ketoacidosis
AIM: Poorer glycemic control and higher diabetic ketoacidosis (DKA) rates are seen in racial/ethnic minorities with type 1 diabetes (T1D). Use of diabetes technologies such as continuous glucose monitors (CGM), continuous subcutaneous insulin infusion (CSII) and automated insulin delivery (AID) syst...
Autores principales: | Conway, Rebecca Baqiyyah, Gerard Gonzalez, Andrea, Shah, Viral N, Geno Rasmussen, Cristy, Akturk, Halis Kaan, Pyle, Laura, Forlenza, Gregory, Alonso, Guy Todd, Snell-Bergeon, Janet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404403/ https://www.ncbi.nlm.nih.gov/pubmed/37551339 http://dx.doi.org/10.2147/DMSO.S416192 |
Ejemplares similares
-
Assessing the relationship between low-calorie sweetener use and quality of life measures in adults with type 1 diabetes
por: Akturk, Halis K, et al.
Publicado: (2023) -
Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar(®) in Type 1 Diabetes Management
por: Garg, Satish K., et al.
Publicado: (2017) -
Inequity in Racial-Ethnic Representation in Randomized Controlled Trials of Diabetes Technologies in Type 1 Diabetes: Critical Need for New Standards
por: Akturk, Halis K., et al.
Publicado: (2021) -
Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study
por: Akturk, Halis Kaan, et al.
Publicado: (2018) -
Acute presentation of immunotherapy-related diabetes mellitus without ketoacidosis, low C-peptide or elevated HbA1c
por: Phang, Cun An, et al.
Publicado: (2022)